The purpose of this study was 
Introduction
Nitric oxide (NO), formed from the guanadino nitrogen of L-arginine by the action of NO synthase, was originally described as an endothelium-derived vasodilator (Palmer et al, 1987) . NO is widely distributed and its many roles include action as a smooth muscle relaxant, a neurotransmitter and as a bactericidal agent (Moneada and Higgs, 1993) . In the repro¬ ductive tract, NO is implicated in the physiology of menstru¬ ation and, during pregnancy, disorders of the L-arginine-NO pathway may contribute to the pathophysiology of pre¬ eclampsia and intrauterine growth retardation (Norman and Cameron, 1996) . The potential efficacy of NO as a uterine relaxant has been demonstrated in rats, in which NO acts as a smooth muscle relaxant in the myometrium. NO inhibits spontaneous contractions in vitro (Yallampalli et al, 1993a) ; and a reduction in endogenous NO is implicated in the mechanism of the onset of labour (Yallampalli et al, 1994) .
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An agent that effectively inhibits myometrial contractions in women is urgently required for the treatment of preterm labour, a condition that contributes to the premature delivery and death of over 1000 infants in the UK annually (Office of Population Censuses and Surveys, 1993) . Two previous studies have suggested that NO donors inhibit human myometrial contractility (Buhimschi et al, 1995; Lee and Chang, 1995) . However, the NO donors used in these studies, diethylamine/ NO, and streptozotocin, which releases NO under ultra¬ violet radiation, are not currently available for use in vivo. In contrast, glyceryl trinitrate (GTN) and sodium nitroprusside (SNP) (Fig. 3b) . (Fig. 4b) , with the highest concentration suppressing activity completely. (Buhimschi et al, 1995) . Furthermore, the generation of NO from the ultraviolet irradiation of streptozotocin (1 (Bolotina et al, 1994 (Buhimschi et al, 1995) . The effect of endogenous NO production within the myometrium was determined by apply¬ ing L-NAME, an inhibitor of NO synthesis, to myometrial strips. In our experiments, l-NAME (0.3 mmol 1~) had no effect on myometrial contractions, implying that there is no endogenous NO production within the myometrium in vitro. These results are in agreement with data reported by Jones and Poston (1997) . In contrast, a modest increase in the contrac¬ tions of myometrium from pregnant women occurred in response to the NO synthase inhibitor W'-nitro-L-arginine (l-NNA) at concentrations of 0.3 mmol 1~( Lee and Chang, 1995) and in the contractions of myometrium from non¬ pregnant women in response to i-NAME (1 mmol 1_1) or l-NNA (1 mmol l"1) (Buhimschi et al, 1995 (Caritis el al, 1979; Morrison et al, 1993 
